Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email Cadwalader is pleased to be advising Salix Pharmaceuticals, Ltd. in its announced combination with Cosmo Technologies Limited, a subsidiary of Cosmo Pharmaceuticals S.p.A., pursuant to which Salix will become a wholly-owned subsidiary of Irish incorporated Cosmo Technologies, which will change its name to Salix Pharmaceuticals, plc. https://www.cadwalader.com/news/news-release/cadwalader-advising-salix-pharmaceuticals-in-its-combination-with-cosmo-technologies-to-form-salix-pharmaceuticals-plc